Emergency Management: Hyperglycemic Crisis with Suspected DKA or HHS
This patient requires immediate emergency department evaluation for a hyperglycemic crisis—specifically diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)—given the blood glucose of 365 mg/dL, one week of missed insulin/GLP-1 therapy, and acute symptoms of nausea, vomiting, and dizziness.
Immediate Assessment Required
Check ketones immediately (blood beta-hydroxybutyrate preferred over urine ketones) to differentiate between DKA and HHS, as this determines ICU-level care needs 1. The clinical presentation—missed insulin for one week with GI symptoms—strongly suggests a hyperglycemic emergency rather than simple hyperglycemia.
Critical Laboratory Tests Needed STAT:
- Blood glucose (already 365 mg/dL = 20.3 mmol/L)
- Venous blood gas (arterial not necessary initially) for pH and bicarbonate
- Serum ketones (beta-hydroxybutyrate) or urine ketones
- Complete metabolic panel including sodium, potassium, chloride, bicarbonate, BUN, creatinine
- Calculated serum osmolality to assess for HHS (>320 mOsm/L indicates HHS)
- Anion gap calculation
- Phosphate and calcium
Treatment Algorithm Based on Ketone Results
If Ketonemia ≥1.5 mmol/L or Ketonuria ≥2+:
Transfer to ICU for continuous IV insulin infusion 1. This indicates DKA or mixed DKA/HHS requiring intensive monitoring.
Fluid resuscitation is the priority:
- Start with 0.9% normal saline at 15-20 mL/kg/hour for the first 1-2 hours (approximately 1-1.5 L for most adults)
- Never use hypotonic fluids initially 4
- Transition to 0.45% saline once hemodynamically stable and sodium is normal/elevated
- Add dextrose (D5W) to IV fluids once glucose falls to 200-250 mg/dL to prevent hypoglycemia while continuing insulin to clear ketones 2
Insulin therapy:
- Continuous IV insulin infusion at 0.1 units/kg/hour (no initial bolus needed in most protocols)
- Target glucose reduction of 50-75 mg/dL per hour
- Do not stop insulin until ketones clear, even if glucose normalizes—continue insulin with dextrose-containing fluids 2, 3
Potassium replacement is critical:
- Check potassium before starting insulin
- If K+ <3.3 mEq/L: hold insulin and give potassium first
- If K+ 3.3-5.0 mEq/L: add 20-30 mEq potassium to each liter of IV fluid
- Monitor potassium every 2-4 hours (hypokalaemia occurs in ~50% during treatment and increases mortality) 3
If Ketonemia 0.5-1.5 mmol/L or Ketonuria 1+:
Give 6 units rapid-acting insulin subcutaneously and recheck glucose and ketones in 3 hours 1. Start aggressive IV hydration with 0.9% saline. If ketones worsen or glucose remains >300 mg/dL, escalate to ICU-level continuous insulin infusion.
If No Ketosis (Ketonemia <0.5 mmol/L, Ketonuria 0):
Suspect HHS, especially given the patient's age (54 years) and Type 2 diabetes profile (on GLP-1 therapy). HHS has 10-fold higher mortality than DKA 5.
- Check serum osmolality urgently: >320 mOsm/L confirms HHS 1
- Clinical signs: profound dehydration, altered mental status (dizziness may indicate early confusion), no significant acidosis
- Requires ICU admission for aggressive fluid resuscitation (often 6-10 L deficit)
- Start subcutaneous rapid-acting insulin 6 units and initiate IV hydration 1
- May still require IV insulin infusion if glucose remains severely elevated
Critical Pitfalls to Avoid
Do not rely on glucose level alone to distinguish DKA from HHS—glucose of 365 mg/dL can occur in either condition. The presence/absence of ketones and degree of acidosis are diagnostic 6, 5.
Do not stop IV insulin when glucose normalizes in DKA—ketone clearance lags behind glucose correction. Continue insulin with dextrose-containing fluids until ketones resolve (pH >7.3, bicarbonate >18 mEq/L) 2.
Monitor for cerebral edema during treatment, though more common in children. Avoid overly rapid correction of glucose and osmolality 2.
The missed GLP-1 therapy is relevant: GLP-1 agonists slow gastric emptying, and their sudden discontinuation may have contributed to poor glycemic control, but the primary issue is missed insulin causing absolute insulin deficiency 7.
Resolution Criteria Before Discharge
For DKA resolution 2:
- Glucose <200 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH >7.3
- Anion gap normalized
Transition from IV to subcutaneous insulin: Give first dose of subcutaneous basal insulin 1-2 hours before stopping IV insulin to prevent rebound hyperglycemia 3, 8.
Post-Acute Management
Once stabilized, calculate total daily insulin requirement from the IV infusion rate over the last 12-24 hours. Give approximately 50% as basal insulin (long-acting) and divide the remainder as prandial doses (rapid-acting) with meals 1.
Address medication non-adherence: This is the most common precipitating factor for recurrent DKA in established diabetes 4, 9. Arrange immediate diabetes education, assess financial barriers to insulin access, and ensure close follow-up within 1-2 weeks 10, 8.
The 4 days of dizziness preceding acute symptoms suggests progressive metabolic decompensation—this was not a sudden event but rather evolving hyperglycemic crisis from prolonged insulin omission.